Journal of the Chemical Society Chemical Communications · 1989 · 22 citations · 0 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoverySynthetic Medicinal ChemistryAntibacterial PharmacologyStructure-activity Relationship AnalysisBeta-lactamase InhibitorsNovel Beta-lactamase Discovery
The key step in the preparation of the title compound (BRL 42715) from 6-aminopenicillanic acid was the condensation of the anion, generated by deprotonation of p-methoxybenzyl (5R,6S)-6-bromopenem-3-carboxylate(10), with 1-methyl-1,2,3-triazole-4-carbaldehyde; in situ acylation, followed by reductive elimination afforded the isomeric (Z)- and (E)-6-triazolylmethylene penem esters, (12) and (13) respectively.